MoonLake Immunotherapeutics - Class A Ordinary Shares (MLTX) earnings
MLTX earnings moved a median of -0.34% by the close. Quarterly and annual MLTX reports and results, each read against the price at its own news timestamp. Back to the MLTX overview →
12 measured MLTX earnings events.
Where these MLTX earnings landedvs 11 measured MLTX earnings reactions
| Middle 50% of MLTX earnings reactions | -1.46% to +0.43% |
|---|---|
| Median reaction (to close) | -0.34% |
| Measured reactions | 11 |
Point-in-time · zero look-ahead
Half of the 11 MLTX earnings events with a measured close landed between -1.46% and +0.43%; 36% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q MoonLake Immunotherapeut For: Jun 30 | SEC filing · Form 10-Q | -0.76% | — | |
| Form 10-Q MoonLake Immunotherapeut For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +3.29% | |
| Form 10-K MoonLake Immunotherapeut For: Dec 31 | SEC filing · Form 10-K | +3.92% | +0.66% | |
| Form 10-Q MoonLake Immunotherapeut For: Sep 30 | SEC filing · Form 10-Q | -3.03% | +0.19% | |
| Form 10-Q MoonLake Immunotherapeut For: Jun 30 | SEC filing · Form 10-Q | -1.04% | -0.39% | |
| Form 10-Q MoonLake Immunotherapeut For: Mar 31 | SEC filing · Form 10-Q | -2.79% | -5.03% | |
| Form 10-K MoonLake Immunotherapeut For: Dec 31 | SEC filing · Form 10-K | +1.55% | +5.74% | |
| Form 10-Q MoonLake Immunotherapeut For: Sep 30 | SEC filing · Form 10-Q | +0.06% | -2.52% | |
| Form 10-Q MoonLake Immunotherapeut For: Jun 30 | SEC filing · Form 10-Q | -1.04% | -3.41% | |
| Form 10-K/A MoonLake Immunotherapeut For: Dec 31 | SEC filing · Form 10-K | +0.39% | -0.34% | |
| Form 10-Q MoonLake Immunotherapeut For: Mar 31 | SEC filing · Form 10-Q | +0.39% | -0.34% | |
| MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update | Press release | +0.39% | -0.34% |
Keep exploring
More MLTX: analyst actions → · SEC filings → · MLTX overview →